155 related articles for article (PubMed ID: 14983618)
21. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
[TBL] [Abstract][Full Text] [Related]
22. Medicare prescription drug/reform act: medicine chest or Pandora's box?
Hager MH
J Am Diet Assoc; 2004 Jun; 104(6):890-1. PubMed ID: 15175585
[No Abstract] [Full Text] [Related]
23. Helping low-income patients obtain prescription medications.
Gottlieb JL
Arch Ophthalmol; 2002 Nov; 120(11):1575-6. PubMed ID: 12427075
[TBL] [Abstract][Full Text] [Related]
24. The impact of Medicare Part D on prescription drug use by the elderly.
Lichtenberg FR; Sun SX
Health Aff (Millwood); 2007; 26(6):1735-44. PubMed ID: 17978393
[TBL] [Abstract][Full Text] [Related]
25. When poor patients can't pay.... Drug assistance programs will.
Tumolo J
Adv Nurse Pract; 2001 May; 9(5):69-72. PubMed ID: 12400264
[No Abstract] [Full Text] [Related]
26. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
[TBL] [Abstract][Full Text] [Related]
27. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Emmer S; Allendorf L
J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
[No Abstract] [Full Text] [Related]
28. Medicare coverage of prescription drugs.
Division of Advocacy and Health Policy
Bull Am Coll Surg; 2005 Sep; 90(9):29-30, 62. PubMed ID: 18435099
[No Abstract] [Full Text] [Related]
29. Part I--Medicare prescription drug coverage (Part D): the promise.
Witten B
Nephrol News Issues; 2006 Jul; 20(8):14, 17-8. PubMed ID: 16859229
[No Abstract] [Full Text] [Related]
30. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
Fise T
Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
[No Abstract] [Full Text] [Related]
31. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
32. Prescription benefit costs rise less steeply.
Manag Care; 2008 Jun; 17(6):53. PubMed ID: 18624171
[No Abstract] [Full Text] [Related]
33. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
34. Drug-plan sponsors prepare for Medicare 'marketing blitz'.
Med Health; 2005 Aug; 59(26):1, 6-7. PubMed ID: 16116671
[No Abstract] [Full Text] [Related]
35. Affordable prescription drugs--state and federal action.
Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
[No Abstract] [Full Text] [Related]
36. New York Medicaid: never can say goodbye.
Fastiggi J
Cornell J Law Public Policy; 2007; 16(3):581-615. PubMed ID: 18521998
[No Abstract] [Full Text] [Related]
37. The Health and Wellness Trust Fund Commission.
Davis JW
N C Med J; 2002; 63(3):165-6. PubMed ID: 12181852
[No Abstract] [Full Text] [Related]
38. Industry warily eyes new Medicare drug plan.
Vastag B
Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141
[No Abstract] [Full Text] [Related]
39. Prescription drugs and the changing concentration of health care expenditures.
Zuvekas SH; Cohen JW
Health Aff (Millwood); 2007; 26(1):249-57. PubMed ID: 17211035
[TBL] [Abstract][Full Text] [Related]
40. Helping needy patients get needed medications.
McTavish L; Gray S
Fam Pract Manag; 2005 Jun; 12(6):55-8. PubMed ID: 16010881
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
